Vasilios Tzilas - Concepedia

Author

Vasilios Tzilas

National and Kapodistrian University of Athens ORCID

Also Known As

Demosthenes Bouros, Dirk Skowasch, Guy Brusselle, V Tzilas, V. TZILAS, V. Tzilas, V., Tzilas, Vasilios Tzilas, Vasilis Tzilas, Vassilios Tzilas

128

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Sotiria General Hospital University of Crete Democritus University of Thrace Alexander Fleming Biomedical Sciences Research Center

About

Vasilios Tzilas is an author at National and Kapodistrian University of Athens specializing in medicine, pulmonary fibrosis, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	321
2	Engineering	1	1	34
3	Biostatistics	1	1	34
4	Data Science	1	1	34
5	Health Informatics	1	1	34

Vasilios Tzilas

Publications

607

Citations

H-Index

Page 1

	Year	Citations
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis Vasilios Tzilas, Evangelos Bouros, Ilianna Barbayianni, Pulmonary Pharmacology & Therapeutics Experimental Lung FibrosisAntifibrotic TherapyInflammatory Lung DiseaseLung InflammationIdiopathic Pulmonary Fibrosis	2019	89
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis Τheodoros Karampitsakos, Sebastiano Emanuele Torrisi, Effrosyni D. Manali, Respiratory Research	2021	69
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, ERJ Open Research	2020	60
Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece Argyrios Tzouvelekis, Τheodoros Karampitsakos, Maria Kontou, Pulmonary Pharmacology & Therapeutics Antifibrotic TherapyAdvanced Lung DiseaseIdiopathic Pulmonary FibrosisPulmonary FibrosisMedicine	2018	59
Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis Αrgyris Τzouvelekis, Τheodoros Karampitsakos, Sofia Kourtidou, Frontiers in Medicine	2020	54
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece Αrgyris Τzouvelekis, Τheodoros Karampitsakos, Georgia Gomatou, Pulmonary Pharmacology & Therapeutics Antifibrotic TherapyAdvanced Lung DiseaseMedicineIdiopathic Pulmonary FibrosisPathology	2019	52
Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study Argyrios Tzouvelekis, Paschalis Ntolios, Τheodoros Karampitsakos, Pulmonary Pharmacology & Therapeutics Antifibrotic TherapyAdvanced Lung DiseaseMedicinePulmonary PharmacologyPulmonary Fibrosis	2017	46
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece Argyrios Tzouvelekis, Τheodoros Karampitsakos, Paschalis Ntolios, Frontiers in Medicine	2017	44
2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis Vasilios Tzilas, Argyrios Tzouvelekis, Jay H. Ryu, The Lancet Respiratory Medicine FibrosisAdvanced Lung DiseaseIdiopathic Pulmonary FibrosisPulmonary FibrosisPulmonary Medicine	2022	41
Towards the adoption of quantitative computed tomography in the management of interstitial lung disease Simon Walsh, Jan De Backer, Helmut Prosch, European Respiratory Review Computed TomographyArtificial IntelligenceEngineeringAdvanced Lung DiseaseDiagnosis	2024	34

Page 1